🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
China flag China · Delayed Price · Currency is CNY
4.840
-0.240 (-4.72%)
Nov 20, 2026, 3:04 PM CST

SHE:300639 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
631.05659.03806.721,0755,5192,647
Other Revenue
10.6110.618.8129.7578.3526.43
641.66669.64815.531,1045,5972,673
Revenue Growth
-7.16%-17.89%-26.16%-80.27%109.39%97.34%
Cost of Revenue
365.52377.36440.35442.11,807865.5
Gross Profit
276.14292.28375.18662.353,7901,808
Selling, General & Admin
294.47373.38482532.48847.68581.7
Research & Development
56.4262.3985.64136.32247.28115.29
Other Operating Expenses
16.6410.9410.819.9321.312.88
Operating Expenses
245.38480.681,185667.971,367761.63
Operating Income
30.76-188.4-810.23-5.622,4241,046
Interest Expense
-2.05-3.18-1.58-4.94-8.18-7.4
Interest & Investment Income
19.418.4127.447.4536.424.42
Currency Exchange Gain (Loss)
22.7522.75-20.95-15.89-2.360.86
Other Non Operating Income (Expenses)
32.66-0.97-1.82-1.55-2.29-1.21
EBT Excluding Unusual Items
103.51-151.39-807.1919.442,4471,063
Gain (Loss) on Sale of Investments
11.383.854.05-00.040.14
Gain (Loss) on Sale of Assets
-1.410.43-0.257.064.342.34
Asset Writedown
-5.66-15.62-24.791.56-291.74-6.42
Other Unusual Items
-12.19-6.59-4.798.76-31.96-1.44
Pretax Income
95.63-169.32-832.9736.822,1281,057
Income Tax Expense
21.4412.96117.38-31.7326.06172.24
Earnings From Continuing Operations
74.19-182.28-950.3568.511,802884.94
Minority Interest in Earnings
-7.5251.34295.4771.96-75.81-32.78
Net Income
66.67-130.94-654.88140.471,726852.16
Net Income to Common
66.67-130.94-654.88140.471,726852.16
Net Income Growth
----91.86%102.54%134.97%
Shares Outstanding (Basic)
626624642-659659
Shares Outstanding (Diluted)
626624642-659659
Shares Change
-1.98%-2.88%---0.02%7.39%
EPS (Basic)
0.11-0.21-1.02-2.621.29
EPS (Diluted)
0.11-0.21-1.02-2.621.29
EPS Growth
----102.58%118.80%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
225.33249.21-69.55-65.72574.85-9.73
Free Cash Flow Per Share
0.360.40-0.11-0.87-0.01
Dividend Per Share
---0.0650.2330.155
Dividend Growth
----72.14%50.03%74.13%
Gross Margin
43.04%43.65%46.01%59.97%67.72%67.62%
Operating Margin
4.79%-28.13%-99.35%-0.51%43.30%39.13%
Profit Margin
10.39%-19.55%-80.30%12.72%30.84%31.88%
Free Cash Flow Margin
35.12%37.22%-8.53%-5.95%10.27%-0.36%
EBITDA
175.46-36.92-649.72159.932,5911,127
EBITDA Margin
27.34%-5.51%-79.67%14.48%46.29%42.17%
D&A For EBITDA
144.7151.48160.51165.55167.2981.33
EBIT
30.76-188.4-810.23-5.622,4241,046
EBIT Margin
4.79%-28.13%-99.35%-0.51%43.30%39.13%
Effective Tax Rate
22.42%---15.32%16.29%
Revenue as Reported
641.66669.64815.531,1045,5972,673
Advertising Expenses
-9.8914.3124.236.329.35